Navigation Links
PET tracer changes management plan for brain tumor patients
Date:3/1/2012

Reston, Va. (March 1, 2012) Imaging amino acid transporters with positron emission tomography/computed tomography (PET/CT) has been shown to significantly alter intended management plans for patients with brain tumors, according to research in the March issue of The Journal of Nuclear Medicine. As a result of imaging with the radiopharmaceutical 3,4-dihydroxy-6-F-18-fluoro-L-phenylalanine (F-18-DOPA), physicians changed the intended management plan for 41 percent of patients with brain tumors.

Contrast-enhanced magnetic resonance imaging (MRI) is most frequently used to diagnose and monitor patients with brain tumors. After initial treatment, however, the assessment of recurrence by MRI can be difficult since contrast enhancement cannot reliably distinguish tumor recurrence from radiation necrosis. PET/CT imaging provides a highly accurate image that is beneficial for detecting primary and recurrent high- and low-grade brain tumors.

In the study, "Impact of 3,4-Dihydroxy-6-F-18-Fluoro-L-Phenylalanine PET/CT on Managing Patients with Brain Tumors: The Referring Physician's Perspective," referring physicians were given a survey prior to performing PET/CT scans with F-18-DOPA on patients with known or suspected brain tumors. The pre-scan surveys asked about indication, tumor histology or grade, level of suspicion for tumor recurrence and planned management. Soon after the PET/CT scans, the referring physicians were asked to complete a survey to categorize PET findings, level of suspicion for primary or recurrent brain tumors and intended management changes. Six months following the scans, the physicians took another survey dealing with recurrence and survival.

Of the 58 cases that were included in the survey, the clinical suspicion for recurrence increased in 33 percent, remained unchanged in 50 percent and decreased in 17 percent of patients after adding the PET/CT findings to other diagnostic data. As a result, several changes in management were recommended, with changes from "watch and wait" to chemotherapy (25 percent) and from chemotherapy to "watch and wait" (17 percent) occurring most frequently. Seventy-five percent of the recommended changes were implemented.

"We know that F-DOPA PET/CT imaging is highly accurate for detecting brain tumors, and in our research we've shown that this imaging modality has a significant impact on patient management," said Johannes Czernin, MD, one of the authors of the study. "In the future, we will initiate multicenter trials to determine whether these management changes have an impact on patient outcome. We believe that amino-acid transport imaging with PET will eventually be an important and frequently used imaging modality in brain cancer."

According to the American Brain Tumor Association, an estimated 64,530 new cases of primary brain tumors were expected to be diagnosed last year. It is estimated that during the year 2004 more than 612,000 people in the United States were living with the diagnosis of a primary brain or central nervous system tumor. The five year survival rates vary among tumor subtypes and range from 3.3 percent for high-grade tumors to 70 percent for low-grade tumors.


'/>"/>

Contact: Susan Martonik
smartonik@snm.org
703-652-6773
Society of Nuclear Medicine
Source:Eurekalert

Related medicine news :

1. Groundbreaking Study Using Ultrasound for the Treatment of Intracerebral and Intraventricular Hemorrhage Stroke Shows Promise
2. Novel radiotracer shines new light on the brains of Alzheimers disease patients
3. Physical Changes in Brain Linked to Altered Spirituality
4. Northern California Cancer Center Changes Name to Cancer Prevention Institute of California
5. Medicare Advantage Members May Make Changes During Open Enrollment
6. CMS Watch Changes Name to The Real Story Group
7. Changes during menopause increases risk of heart disease and stroke
8. Childhood stress such as abuse or emotional neglect can result in structural brain changes
9. Dmatek Changes its Name to Attenti
10. Long Island Pediatric Group Announces Policy Changes That Will Help More New Yorkers
11. YourHCG.com Changes the Way People Lose Weight by Offering an Affordable HCG Diet Plan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... (PRWEB) , ... June 26, 2016 , ... Pixel Film ... Pro X. , "Film editors can give their videos a whole new perspective by ... Austin - CEO of Pixel Film Studios. , ProSlice Levels contains over 30 ...
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs ... College of Mohs Surgery and to Dr. Russell Peckham for medical and surgical dermatology. ... treatment for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson ... Recently, he has implemented orthobiologic procedures as a method for treating his patients. ... the first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons ...
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is World Sickle Cell ... pain and the benefits of holistic treatments, Serenity Recovery Center of Marne, ... Cell Disease. , Sickle Cell Disease (SCD) is a disorder of the red blood ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San Diego, CA ... the Road To Recovery® program to drive cancer patients to and from their cancer ... ensure the highest quality of life and ongoing independence. Getting to and from ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016 VolitionRx ... of Dr. Edward Futcher to the ... effective June 23, 2016.Dr. Futcher was also appointed ... Governance Committees.  As a non-executive member of the ... and strategic counsel to VolitionRx in connection with ...
(Date:6/23/2016)... -- MedSource announced today that it has selected Datatrial,s ... choice.  This latest decision demonstrates MedSource,s commitment to ... by offering a state-of-the-art electronic data capture (EDC) ... the EDC platform of choice in exchange for ... long been a preferred EDC platform by our ...
(Date:6/23/2016)... , June 23, 2016 Any dentist who ... challenges of the current process. Many of them do not ... the technical difficulties and high laboratory costs involved. And those ... offer it at such a high cost that the majority ... Dr. Parsa Zadeh , founder of Dental ...
Breaking Medicine Technology: